Universe Pharmaceuticals INC (UPC) income statement
UPCNasdaqPharmaceutical PreparationsFiscal year ends September 30
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Sep 30, 2025Last filing: 20-F on Jan 29, 2026Score 5/30
$1.52−0.04 (-2.48%)
Close on Nov 18, 2026Market cap $857.01KP/E –Yield –
Universe Pharmaceuticals INC income statement
Ratios
Latest available, balances at Mar 31, 2026
Profitability, FY2025
- Gross margin
- 35.3%
- Operating margin
- -16.3%
- Net margin
- -20.6%
- Return on equity, FY2025
- -7226.1%
Financial strength
- Current ratio
- 4.05
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 202.0%
Valuation
- P/E ratio
- –
- Price to sales
- 0.00
- Price to book
- 0.02
- Dividend yield
- –
See a number that looks wrong?